Target intelligence / Profile preview

No pharmacological molecular target

Molecular classification
Other
01

Overview

The designation "No pharmacological molecular target" is used in pharmacology to categorize therapeutic agents that do not exert their effects by binding to a specific biological macromolecule, such as a receptor, enzyme, or ion channel (ChEMBL, 2024). Instead, these agents typically function through physical or chemical processes that alter the physiological environment. For example, antacids neutralize gastric acid via a direct chemical reaction, while osmotic laxatives increase stool water content through physical-chemical gradients (StatPearls, 2023). This category also includes agents like activated charcoal, which acts by physically adsorbing toxins in the gastrointestinal tract, and inert contrast media used in medical imaging (PubMed, 2022). Because these substances lack a specific molecular site of action, they often exhibit broad effects and are not subject to traditional structure-activity relationship (SAR) optimization. Understanding this classification is essential for distinguishing between targeted therapies and those that modify the physiological environment through non-specific means.

Other names
Non-molecular targetNon-specific mechanismPhysical/chemical actionNo protein target
02

Mechanism of action

Drugs associated with this label typically act through physical or chemical means rather than binding to a specific protein or nucleic acid. Examples include the chemical neutralization of acid, osmotic pull of water, or physical adsorption of molecules (DrugBank, 2024).

03

Biological functions

Other
04

Disease associations

Other
05

Safety considerations

Interference with absorption of co-administered medicationsElectrolyte disturbancesGastrointestinal obstruction
06

Interacting drugs

Activated charcoal

5 more in the full profile.

Beyond the preview

Go deeper on No pharmacological molecular target.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on No pharmacological molecular target.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call